Regions of interest (ROI) were selected based on Ki67 positivity (tumor-enriched regions) and immunofluorescence imaging of CD45, CD68, and tumor marker synaptophysin expression (Figure 4A) to scan tumor regions. Here, CD68 is linked to neoplasm.